Discontinuation report CEENU
Report ID | 48137 |
Drug Identification Number | 00360414 |
Brand name | CEENU |
Common or Proper name | Lomustine |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LOMUSTINE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 1 BTL x 20 |
ATC code | L01AD |
ATC description | ALKYLATINGAGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-08-30 |
Actual discontinuation date | 2019-09-30 |
Remaining supply date | 2019-08-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | CEENU 10MG AND 40MG will still be available. Only the 100mg strength is being discontinued. |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-02-10 | French | Compare |
v11 | 2022-02-10 | English | Compare |
v10 | 2022-02-10 | French | Compare |
v9 | 2022-02-10 | English | Compare |
v8 | 2022-02-10 | French | Compare |
v7 | 2022-02-10 | English | Compare |
v6 | 2019-01-02 | French | Compare |
v5 | 2019-01-02 | English | Compare |
v4 | 2018-12-03 | French | Compare |
v3 | 2018-12-03 | English | Compare |
v2 | 2018-05-02 | French | Compare |
v1 | 2018-05-02 | English | Compare |
Showing 1 to 12 of 12